|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2010-9-2
|
|
pubmed:abstractText |
Treatment with antipsychotics can be associated with weight gain, and second-generation (atypical) antipsychotics (SGAs) can increase the risk for diabetes and dyslipidemia. These risks have not been assessed in patients with tics, who receive lower doses than those used to treat psychosis. The objective of this study is to investigate the relationship between antipsychotic use and weight in tic patients and compare the effects of SGAs to first-generation (typical) antipsychotics (FGAs).
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1557-8992
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
277-81
|
|
pubmed:meshHeading |
pubmed-meshheading:20807065-Adolescent,
pubmed-meshheading:20807065-Adult,
pubmed-meshheading:20807065-Aged,
pubmed-meshheading:20807065-Antipsychotic Agents,
pubmed-meshheading:20807065-Body Mass Index,
pubmed-meshheading:20807065-Body Weight,
pubmed-meshheading:20807065-Child,
pubmed-meshheading:20807065-Child, Preschool,
pubmed-meshheading:20807065-Dose-Response Relationship, Drug,
pubmed-meshheading:20807065-Female,
pubmed-meshheading:20807065-Humans,
pubmed-meshheading:20807065-Male,
pubmed-meshheading:20807065-Middle Aged,
pubmed-meshheading:20807065-Risk Factors,
pubmed-meshheading:20807065-Tic Disorders,
pubmed-meshheading:20807065-Young Adult
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Association between antipsychotics and body mass index when treating patients with tics.
|
|
pubmed:affiliation |
Department of Neurological Sciences, Rush University Medical Center, Chicago, Illionois 60612, USA. kkompoli@rush.edu
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
